Drug Trial Radar · NCT05077904
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
350
Planned (sponsor's estimate)
Start
Dec 7, 2021
Primary completion
Mar 29, 2027
Study completion Mar 29, 2027
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- First posted
- Oct 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the success of a single administration of Staccato alprazolam compared with placebo both in rapidly terminating a seizure episode within 90 seconds and with no recurrence of seizure(s) up to 2 hours after investigational medicinal product (IMP) administration.
Conditions
- Stereotypical Prolonged Seizures
Interventions
Staccato alprazolamDrug
Route of administration: Inhalation Participants will receive one dose of Staccato alprazolam during the Treatment Period.
PlaceboOther
Route of administration: Inhalation Participants will receive one dose of placebo during the Treatment Period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment success for the treated seizure within 90 seconds after investigational medicinal product (IMP) administrationTime frame: From start of IMP treatment through 6 hours
- Treatment success for the treated seizure with no recurrence up to 2 hoursTime frame: From start of IMP treatment through 2 hours
Locations
183 sites in 13 countries. Site status is shown where the registry gives one.
Ep0162 50506
Phoenix, Arizona · Recruiting
Ep0162 50720
Scottsdale, Arizona · Recruiting
Ep0162 50494
Little Rock, Arkansas · Completed
Ep0162 50118
Downey, California · Recruiting
Ep0162 50416
La Jolla, California · Recruiting
Ep0162 50702
Long Beach, California · Recruiting
Ep0162 50505
Los Angeles, California · Withdrawn
Ep0162 50492
Orange, California · Completed
Ep0162 50722
Poway, California · Withdrawn
Ep0162 50716
Sacramento, California · Recruiting
Ep0162 50367
New Haven, Connecticut · Completed
Ep0162 50088
Washington D.C., District of Columbia · Recruiting
Ep0162 50721
Boca Raton, Florida · Withdrawn
Ep0162 50515
Gulf Breeze, Florida · Completed
Ep0162 50508
Jacksonville, Florida · Recruiting
Ep0162 50342
Jacksonville, Florida · Recruiting
Ep0162 50199
Miami, Florida · Recruiting
Ep0162 50676
Miami, Florida · Recruiting
Ep0162 50509
Orlando, Florida · Completed
Ep0162 50703
Rockledge, Florida · Recruiting
Ep0162 50308
Tampa, Florida · Recruiting
Ep0162 50323
Honolulu, Hawaii · Recruiting
Ep0162 50512
Boise, Idaho · Recruiting
Ep0162 50493
Chicago, Illinois · Recruiting
Ep0162 50375
Springfield, Illinois · Withdrawn
Ep0162 50504
Fort Wayne, Indiana · Recruiting
Ep0162 50561
Lexington, Kentucky · Withdrawn
Ep0162 50395
New Orleans, Louisiana · Withdrawn
Ep0162 50517
New Orleans, Louisiana · Recruiting
Ep0162 50093
Baltimore, Maryland · Withdrawn
Ep0162 50488
Bethesda, Maryland · Withdrawn
Ep0162 50615
Boston, Massachusetts · Recruiting
Ep0162 50047
Boston, Massachusetts · Completed
Ep0162 50110
Ann Arbor, Michigan · Completed
Ep0162 50507
St Louis, Missouri · Recruiting
Ep0162 50499
Las Vegas, Nevada · Withdrawn
Ep0162 50626
Neptune City, New Jersey · Withdrawn
Ep0162 50299
New Brunswick, New Jersey · Recruiting
Ep0162 50497
Buffalo, New York · Recruiting
Ep0162 50625
New Hyde Park, New York · Completed
Showing 40 of 183 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.